Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: AIDS Behav. 2020 Jun;24(6):1592–1598. doi: 10.1007/s10461-019-02635-0

Table I.

Sample Descriptives for N=245 HIV+ and HIV− Adults and Older Adults

HIV+ (n=174) HIV− (n=71)
Demographics
Age 51.30 (7.03) 61.00 (7.22) <0.01
Aged 50+ 59% 100% <0.01
Gender (% Male) 62% 46% 0.03
Race (% White)a 14% 44% <0.01
Years of education 12.56 (2.16) 13.96 (2.64) <0.01
Verbal IQ 88.63 (14.22) 98.38 (18.28) <0.01
Income 1.94 (1.62) 3.83 (3.04) <0.01
Clinical Variables
Diabetes (% with) 18% 15% 0.73
Stroke (% with) 4% 3% 0.79
Hypertension (% with) 57% 59% 0.80
High Cholesterol (% with) 38% 39% 0.65
Urine screen (% positive for drugs)b 28% 17% 0.10
Estimated years with HIV 16.74 (8.43) -- --
Antiretroviral therapy (% on)c 91% -- --
Viral load (% undetectable)d 66% -- --
Current CD4e 644.40 (364.43) -- --
Nadir CD4f 254.48 (260.89) -- --
Depressive symptoms (% with) 49% 19% <0.01
Neurocognitive impairment (% with) 53% 41% 0.07
Successful Functional Aging Variables
Successful Functional Aging (% Yes) 18% 45% <0.01
 IADL Declines = 0 (% Yes) 51% 69% <0.01
 PAOFI total ≤1 (% Yes) 30% 54% <0.01

Note.

a

97% of HIV+ and 98% of HIV− non-White were African American

b

n=170 HIV+ and n=58 HIV−, drugs include meth, amphetamines, opiates, and cocaine

c

n=169

d

n=146

e

n=124

f

n=157.